Risa Stack GE Ventures

Risa leads the GE Ventures, New Business Creation team that develops and invests in new opportunities in healthcare, energy, and software. The team has launched Evidation Health, Virtruvian Networks, Current Powered by GE, and has several in new businesses in development. Risa joined the GE Ventures team from Kleiner Perkins Caufield & Byers where she was a partner for 10 years. Prior to KPCB, Risa was a Principal at J.P. Morgan Partners. Throughout her VC Career, Risa has invested in and held board director or observer roles in over a dozen healthcare companies including CardioDx, Corthera (acquired by Novartis), Epizyme (NASDAQ: EPZM), Foundation Medicine (NASDAQ:FMI), Ilex Oncology (acquired by Genzyme), Nodality, Orexigen (NASDAQ:OREX), Pacific Biosciences (NASDAQ:PACB), Triangle Pharmaceuticals (acquired by Gilead), Trius (acquired by Cubist), and Veracyte (NASDAQ:VCYT). While at KPCB Risa incubated several companies and was the founding CEO of two. Before joining the venture capital industry, Risa worked as a derivative specialist on the Chicago Board of Trade, where she traded futures and options on government securities. Risa is a member of the steering committee for the Coalition for 21st Century Medicine and on the advisory board of the Personalized Medicine Conference. She was also named as one of the 100 Most Influential Women in Business by the San Francisco Business Times. Risa holds a degree in genetics and development with distinction from the University of Illinois, a Ph.D. in immunology from the University of Chicago, and was a member of the second class of Kauffman Fellows. Risa is an avid athlete; she is currently playing basketball and a regular at bootcamp.